By Pete Brush ( July 26, 2010, 4:25 PM EDT) -- Lawyers for hundreds of Neurontin multidistrict litigation plaintiffs, who accuse Pfizer Inc. of a fraudulent scheme to promote the anti-epilepsy drug for off-label use, have agreed to cut 46 cases from the proceedings, while missing a key deadline to proceed on behalf of more clients....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.